Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus

Gene Therapy volume 6, pages 293–299 (1999)Cite this article

Abstract

Recombinant adeno-associated virus (rAAV) vectors are under consideration for a wide variety of gene therapy applications. One of the limitations of the rAAV vector system has been the difficulty in producing the vector in sufficient quantity for adequate preclinical and clinical evaluation. A common method for vector production involves large-scale transient transfection of multiple plasmids into cultured cells. Because this approach might not be feasible for clinical scale manufacturing, we have sought approaches for rAAV vector production that avoid transient transfection procedures. In previously reported work, we generated an AAV packaging cell line that produces infec- tious rAAV when the vector genome is transfected into the cell line as plasmid DNA. We have now extended this approach by constructing a hybrid recombinant adenovirus (rAd) that contains a complete rAAV vector genome in the E1 region. This hybrid virus is used to deliver the rAAV genome to the packaging cell line (in the place of plasmid transfection). rAAV is produced when the packaging cell line is infected with the hybrid adenovirus and wild-type adenovirus. This method avoids the need for plasmid transfection and is adaptable to large-scale manufacturing processes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Clark KR, Sferra TJ, Johnson PR . Recombinant adeno-associated virus vectors mediate long-term transgene expression in muscle Hum Gene Ther 1997 8: 659–669

    Article  CAS  PubMed  Google Scholar 

  2. Flannery JG et al. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus Proc Natl Acad Sci USA 1997 94: 6916–6921

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Flotte TR et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector Proc Natl Acad Sci USA 1993 90: 10613–10617

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Xiao X, Li J, Samulski RJ . Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J Virol 1996 70: 8098–8108

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Fisher KJ et al. Recombinant adeno-associated virus for muscle directed gene therapy Nature Med 1997 3: 306–312

    Article  CAS  PubMed  Google Scholar 

  6. Koeberl DD et al. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors Proc Natl Acad Sci USA 1997 94: 1426–1431

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain Nat Genet 1994 8: 148–154

    Article  CAS  PubMed  Google Scholar 

  8. Kessler PD et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein Proc Natl Acad Sci USA 1996 93: 14082–14087

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Snyder RO et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors Nat Genet 1997 16: 270–276

    Article  CAS  PubMed  Google Scholar 

  10. Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus J Virol 1998 72: 2224–2232

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Atchison RW, Casto BC, Hammon WM . Adenovirus-associate defective virus particles Science 1965 149: 754–756

    Article  CAS  PubMed  Google Scholar 

  12. Hoggan MD, Blacklow NR, Rowe WP . Studies of small DNA viruses found in various adenovirus preparations: physical, biological and immunological characteristics Proc Natl Acad Sci USA 1966 55: 1457–1471

    Article  Google Scholar 

  13. Buller RM, Janik JE, Sebring ED, Rose JA . Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication J Virol 1981 40: 241–247

    CAS  PubMed  PubMed Central  Google Scholar 

  14. McPherson RA, Rosenthal LJ, Rose JA . Human cytomegalovirus completely helps adeno-associated virus replication Virology 1985 147: 217–222

    Article  CAS  PubMed  Google Scholar 

  15. Allen JM, Debelak DJ, Reynolds TC, Miller AD . Identification and elimination of replication-competent adeno-associated virus (AAV) that arise by nonhomologous recombination during AAV vector production J Virol 1997 71: 6816–6822

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Salvetti A et al. Factors influencing recombinant adeno-associated virus production Hum Gene Ther 1998 9: 695–706

    Article  CAS  PubMed  Google Scholar 

  17. Clark KR, Voulgaropoulou F, Johnson PR . A stable cell line carrying adenovirus inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors Gene Therapy 1996 3: 1124–1132

    CAS  PubMed  Google Scholar 

  18. Clark KR, Voulgaropoulou F, Fraley DM, Johnson PR . Cell line for the production of recombinant adeno-associated virus Hum Gene Ther 1995 6: 1329–1341

    Article  CAS  PubMed  Google Scholar 

  19. Vincent KA, Piraino ST, Wadsworth SC . Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products J Virol 1997 71: 1897–1905

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Li J, Samulski RJ, Xiao X . Role for highly regulated rep gene expression in adeno-associated virus vector production J Virol 1997 71: 5236–5243

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Wang XS, Srivastava A . A novel terminal resolution-like site in the adeno-associated type 2 genome J Virol 1997 71: 1140–1146

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Wistuba A et al. Subcellular compartmentalization of adeno-associated virus type 2 assembly J Virol 1997 71: 1341–1352

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Weger S, Wistuba A, Grimm D, Kleinschmidt JA . Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats and Rep proteins J Virol 1997 71: 8437–8447

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Jones N, Shenk T . An adenovirus type 5 early gene function regulates expression of other early viral genes Proc Natl Acad Sci USA 1979 76: 3665–3669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Pereira DJ, McCarty DM, Muzyczka N . The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection J Virol 1997 71: 1079–1088

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Thrasher AJ et al. Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidase Gene Therapy 1995 2: 481–485

    CAS  PubMed  Google Scholar 

  27. Fisher KJ, Kelly WM, Burda JF, Wilson JM . A novel adenovirus adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome Hum Gene Ther 1996 7: 2079–2087

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Children’s Hospital Research Foundation, The Ohio State University, Columbus, OH, USA

    X L Liu, K R Clark & P R Johnson

  2. Department of Medical Microbiology and Immunology, Children’s Hospital Research Foundation, The Ohio State University, Columbus, OH, USA

    X L Liu, K R Clark & P R Johnson

  3. Department of Molecular Genetics, Children’s Hospital Research Foundation, College of Biological Sciences, The Ohio State University, Columbus, OH, USA

    X L Liu & P R Johnson

  4. Children’s Hospital Research Foundation, College of Medicine, The Ohio State University, Columbus, OH, USA

    P R Johnson

Authors
  1. X L Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K R Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P R Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, X., Clark, K. & Johnson, P. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus. Gene Ther 6, 293–299 (1999). https://doi.org/10.1038/sj.gt.3300807

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300807

Keywords

This article is cited by

Search

Advanced search

Quick links